Friday, April 2, 2021

COVID vaccine effectiveness sustained over time

The Washington Post reports on some good news about a COVID vaccine.

[Good] news emerged from an ongoing trial of the Pfizer-BioNTech vaccine: Six months of follow-up on 12,000 study participants show that the inoculation’s efficacy and safety are sustained over time. The results also suggest that this vaccine is effective against the B.1.351 coronavirus variant first detected in South Africa, which has caused concern for its ability to evade some forms of immunity.

No comments:

Post a Comment